Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T17:39:33.072Z Has data issue: false hasContentIssue false

Energy landscapes in molecular biology: History, principles, and perspectives

Published online by Cambridge University Press:  22 April 2026

Ruth Nussinov*
Affiliation:
Biophysics and Computational Biology Section, Frederick National Laboratory for Cancer Research , Frederick, MD 21702, USA Cancer Innovation Laboratory, National Cancer Institute Frederick , Frederick, MD 21702, USA Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University , Tel Aviv 69978, Israel
Clil Regev
Affiliation:
Cancer Innovation Laboratory, National Cancer Institute Frederick , Frederick, MD 21702, USA
Hyunbum Jang
Affiliation:
Biophysics and Computational Biology Section, Frederick National Laboratory for Cancer Research , Frederick, MD 21702, USA Cancer Innovation Laboratory, National Cancer Institute Frederick , Frederick, MD 21702, USA
*
Corresponding author: Ruth Nussinov; Email: nussinor@mail.nih.gov
Rights & Permissions [Opens in a new window]

Abstract

In an editorial for a Special Issue, Nussinov and Wolynes explored the energy landscapes of biomolecular function, questioning whether they constituted a second molecular biology revolution. With more than a decade having passed and science having progressed significantly, we revisit this question. Statistical energy landscapes not only visualize folding funnels but also quantify the likelihoods of different states, embodying the foundational physical-chemical principles of protein actions. Building upon the theory of energy landscapes, the conformational selection and population shift paradigm posited that since all functional conformations already pre-exist in a dynamic equilibrium, a ligand ‘selects’ and stabilizes a state from this pre-existing pool, resulting in re-equilibration, or shift, of the population. The principle that it established — that function harnesses transitions between pre-existing conformations — revolutionized the understanding of allostery and, broadly, regulation. This paradigm challenged and superseded the decades-old, albeit persisting, belief of only one (or two; ‘open’ and ‘closed’) protein conformations. It also indicates that for engineered proteins to exert effective function, we must account for the timescales of flipping between energy landscape states, for example, by tuning the barrier heights. Returning to the question of whether landscapes constituted a second biomolecular biology revolution, we consider their bedrock contributions, which are far beyond the original protein folding funnels. They established the principle of multiple dynamic conformational states ‘jumping’ over barriers during population shifts. By leveraging core concepts like conformational ensembles, modern molecular biology has achieved breakthroughs such as next-generation allosteric drugs, indeed leading to a transformative era in molecular science.

Information

Type
Review
Creative Commons
This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press.
Copyright
© National Institutes of Health, 2026
Figure 0

Figure 1. Conformational selection illustrated by free energy landscapes of protein folding and a conformational ensemble. (A) A funnel-shaped free energy landscape of protein folding. The lowest free energy region at the bottom contains multiple native-like functional conformational states. (B) A magnified view of the funnel bottom showing a conformational ensemble containing multiple substates with small structural differences, separated by low kinetic barriers (left). A ligand selectively binds to a pre-existing complementary conformation from the native ensemble, stabilizing that specific conformation, making it more energetically favorable and shifting the population distribution toward the ligand-bound substate (right).

Figure 1

Figure 2. Synonymous single-nucleotide polymorphisms (SNPs) in ABCB1. The ABCB1 gene encodes MDR1 (also known as P-glycoprotein 1), a critical membrane pump that removes foreign substances from cells. Synonymous SNPs in ABCB1 are often labeled ‘silent’ because they do not alter the amino acid sequence of P-glycoprotein 1 (top panel). However, the 1236C > T and 3435C > T polymorphisms in ABCB1 demonstrate that these changes are not always functionally neutral. By altering cotranslational folding and membrane insertion timing, these SNPs create alternative protein conformations with distinct substrate-binding affinities. This proves that genetic variations can fundamentally change drug interactions without changing a single amino acid. Membrane-bound P-glycoprotein 1 is a symmetrical transporter composed of two homologous halves (bottom panel). Each half contains an extracellular domain (ECD), a transmembrane domain (TMD), which forms the substrate translocation pathway, intracellular domain (ICD), and a cytoplasmic nucleotide-binding domain (NBD) that provides the ATP-binding pocket. Polymorphisms affect the rate of cotranslational folding and membrane insertion, subtly altering the final structure of these binding pockets. In the apo state (ligand-free), P-glycoprotein 1 adopts a closed inward-facing conformation that covers the substrate-binding site (PDB ID: 9CR8). Binding of a substrate, such as Taxol, to the TMD induces a conformational shift, yielding an open inward-facing conformation that increases NBD affinity for ATP (PDB ID: 9CTF). Upon ATP binding, the protein transitions to an open outward-facing conformation. This reduces substrate affinity and releases the molecule into the extracellular space. Substrate release subsequently leads to a closed outward-facing conformation (PDB ID: 9CTG). Finally, ATP hydrolysis resets the transport cycle. This P-glycoprotein 1 conformational cycle mechanism in the membrane was adopted from the literature (Kurre et al., 2025). Part of graphics created with BioRender.

Figure 2

Figure 3. The energy landscape of intrinsically disordered proteins (IDPs). Unlike globular proteins, which have a deep, narrow folding funnel that leads to a single, low-entropy native state, IDPs have a broad, relatively flat energy landscape (top panel). This landscape is characterized by numerous shallow energy minima and high configurational entropy. These features allow IDPs to exist as a dynamic ensemble of states rather than a single fixed structure. Many IDPs undergo induced folding, a process in which they transition from a disordered state to a structured one when they interact with a partner. This transition involves a significant loss of configurational entropy, a thermodynamically unfavorable change that is typically compensated by the favorable enthalpy generated through new intermolecular interactions. This ‘induced folding’ mechanism is a hallmark of IDP molecular recognition, enabling highly specific yet reversible signaling interactions. The interaction between POSH and Rac1 is a prime example of induced folding in IDPs (bottom panel). POSH (plenty of SH3s), also known as the E3 ubiquitin-protein ligase SH3RF1, acts as a scaffold protein that mediates JNK activation and apoptosis, or programmed cell death. POSH is a multidomain protein composed largely of intrinsically disordered regions; however, binding to active Rac1 triggers a structural transition. Specifically, the disordered POSH segment (residues 323–344) folds into a distinct α-helix–turn–β-strand conformation (PDB ID: 9RFB) upon complex formation.

Figure 3

Figure 4. Conformational switch of Epac2 induced by cAMP. Epac2, also known as RapGEF4, acts as a guanine nucleotide exchange factor (GEF) for small GTPases such as Rap1 and Rap2. Epac2 has multiple isoforms, including Epac2A, Epac2B, and Epac2C (top panel). The canonical form of Epac2 is Epac2A that contains two cyclic nucleotide-binding domains (CNBD-A and CNBD-B) and a Dishevelled, Egl-10, and Pleckstrin (DEP) domain in the N-terminal regulatory domain. The C-terminal catalytic domain contains a Ras exchange motif (REM), a Ras association (RA) domain, and a CDC25 homology domain (CDC25-HD or GEF domain). The CDC25-HD is responsible for activating Rap1. Epac2B lacks the CNBD-A similar to Epac1. Epac2C lacks both CNBD-A and DEP domain. The second messenger cyclic AMP (cAMP) is synthesized from ATP by adenylyl cyclase (AC) in response to the stimulation of Gαs-coupled G protein-coupled receptors (GPCRs) (bottom left panel). Once produced, cAMP binds to the regulatory domain of autoinhibited Epac2, inducing a conformational shift that releases its catalytic domain. This activation allows Epac2 to be recruited by Ras to the plasma membrane, facilitating nucleotide exchange on Rap1. Activated Rap1 then orchestrates a diverse signaling network. It recruits PI3K to promote cell growth and triggers the MAPK pathway to stimulate cell proliferation. Rap1 also engages effectors, such as RIAM, AF-6, and RapL, to regulate cell adhesion, migration, and polarity. Crystal structures of the full-length apo-Epac2 (PDB ID: 2byv, Mus musculus) in surface representation and cAMP-bound, active Epac2 (PDB ID: 3cf, Mus musculus) in cartoon representation (bottom right panel). In the active form, both the CNBD-A and the DEP domain are absent. Rap1, in surface representation, binds to the exposed catalytic core of the CDC25-HD. Part of graphics created with BioRender.